Accepted at 6:34 p.m. Oct, 31, 2023 by Alex
Author: Elijah
Related Note: 1550690802804 2
Rationale for change

According to AMBOSS, aldesterone antagonists should be added to all NYHA stages II-IV HFrEF patients with EF<35%. BiDil is reserved for patients who cannot tolerate ACEIs or ARBs, and some African American patients

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2

Watch Chronic Heart Failure Management Part 2


Watch Unstable Angina & NSTEMI



Watch Hypertension Management
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Review Dobutamine
Physeo
Empty field
Bootcamp
Empty field
OME

Additional Resources
OME:


One by one
Empty field
#AK_Step2_v12::#AMBOSS::xw0EOR #PANCE::CARDIO::heart_failure #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#OME::01_Medicine::01_Cardiology::03_Heart_Failure #AK_Step2_v12::#SketchyIM::01_Cardiology::05_Blood_Pressure::02_HTN_Management #AK_Step3_v12::#OME::Intern_Content::Common_Medical_Problems::CHF_1:_In_the_Clinic #AK_Step2_v12::#Subjects::Cardiology::03_Heart_Failure::Treatment #AK_Step2_v12::Original_decks::Dorian::im::ome::cardio::hf #AK_Step2_v12::#SketchyIM::01_Cardiology::01_Ischemic_Heart_Disease::05_Unstable_Angina/NSTEMI #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::4fm #AK_Step1_v12::#Pixorize::03_Pharmacology::23_Sympathomimetics_&_Sympatholytics_(New)::02_Dobutamine #AK_Step3_v12::#UWorld::12882 #AK_Step2_v12::#Resources_by_rotation::FM::ome::cardio::hf #AK_Step2_v12::#Resources_by_rotation::IM::ome::cardio::hf !AK_UpdateTags::AnKing_Image::Mujeeb::Heart_failure !AK_UpdateTags::Step2decks::Cheesy-Dorian-(M3)::Internal-Medicine::1-OME #AK_Step2_v12::Original_decks::Dorian::fam::ome::cardio::hf #AK_Step2_v12::!Shelf::IM::no_dupes::only_step2 #AK_Step2_v12::#OME::Clinical::01_Medicine::01_Cardiology::03_Heart_Failure #AK_Step2_v12::!Shelf::IM::no_dupes #PANCE::EOR::Family_med #AK_Step2_v12::#B&B::02_Cardiology::03_Heart_Failure::01_02_Heart_Failure #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step2_v12::!Shelf::FM::no_dupes::only_step2 #AK_Step2_v12::#SketchyIM::01_Cardiology::02_Heart_Failure::05_Chronic_Heart_failure_Management_Part_2